85 related articles for article (PubMed ID: 1323646)
21. N-cadherin, beta-catenin and connexin 43 expression in astrocytic tumours of various grades.
Reszec J; Szkudlarek M; Hermanowicz A; Bernaczyk PS; Mariak Z; Chyczewski L
Histol Histopathol; 2015 Mar; 30(3):361-71. PubMed ID: 25386667
[TBL] [Abstract][Full Text] [Related]
22. Developmental regulation of annexin II (Lipocortin 2) in human brain and expression in high grade glioma.
Reeves SA; Chavez-Kappel C; Davis R; Rosenblum M; Israel MA
Cancer Res; 1992 Dec; 52(24):6871-6. PubMed ID: 1333884
[TBL] [Abstract][Full Text] [Related]
23. Up-regulation of urokinase and urokinase receptor genes in malignant astrocytoma.
Gladson CL; Pijuan-Thompson V; Olman MA; Gillespie GY; Yacoub IZ
Am J Pathol; 1995 May; 146(5):1150-60. PubMed ID: 7747809
[TBL] [Abstract][Full Text] [Related]
24. Nuclear factor-kappaB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas.
Angileri FF; Aguennouz M; Conti A; La Torre D; Cardali S; Crupi R; Tomasello C; Germanò A; Vita G; Tomasello F
Cancer; 2008 May; 112(10):2258-66. PubMed ID: 18327814
[TBL] [Abstract][Full Text] [Related]
25. Steroid hormone modulation of vitamin D receptor levels in human MG-63 osteosarcoma cells.
Mahonen A; Mäenpää PH
Biochem Biophys Res Commun; 1994 Dec; 205(2):1179-86. PubMed ID: 7802648
[TBL] [Abstract][Full Text] [Related]
26. The glucose transporter and blood-brain barrier of human brain tumors.
Guerin C; Laterra J; Hruban RH; Brem H; Drewes LR; Goldstein GW
Ann Neurol; 1990 Dec; 28(6):758-65. PubMed ID: 2178329
[TBL] [Abstract][Full Text] [Related]
27. Identification of a novel gene product, RIG, that is down-regulated in human glioblastoma.
Ligon AH; Pershouse MA; Jasser SA; Yung WK; Steck PA
Oncogene; 1997 Mar; 14(9):1075-81. PubMed ID: 9070656
[TBL] [Abstract][Full Text] [Related]
28. Increased expression of diazepam binding inhibitor in human brain tumors.
Alho H; Kolmer M; Harjuntausta T; Helén P
Cell Growth Differ; 1995 Mar; 6(3):309-14. PubMed ID: 7794798
[TBL] [Abstract][Full Text] [Related]
29. Expression of genes belonging to the IGF-system in glial tumors.
Dmitrenko VV; Kavsan VM; Boyko OI; Rymar VI; Stepanenko AA; Balynska OV; Malisheva TA; Rozumenko VD; Zozulya YP
Tsitol Genet; 2011; 45(5):41-57. PubMed ID: 22168049
[TBL] [Abstract][Full Text] [Related]
30. Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.
Mishima K; Kato Y; Kaneko MK; Nishikawa R; Hirose T; Matsutani M
Acta Neuropathol; 2006 May; 111(5):483-8. PubMed ID: 16596424
[TBL] [Abstract][Full Text] [Related]
31. High CHI3L1 expression is associated with glioma patient survival.
Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
[TBL] [Abstract][Full Text] [Related]
32. Promoter hypermethylation-mediated down-regulation of CXCL12 in human astrocytoma.
Zhou W; Jiang Z; Song X; Liu Y; Wen P; Guo Y; Xu F; Kong L; Zhang P; Han A; Yu J
J Neurosci Res; 2008 Oct; 86(13):3002-10. PubMed ID: 18512766
[TBL] [Abstract][Full Text] [Related]
33. Steroid hormone receptors in astrocytic neoplasms.
Carroll RS; Zhang J; Dashner K; Sar M; Black PM
Neurosurgery; 1995 Sep; 37(3):496-503; discussion 503-4. PubMed ID: 7501116
[TBL] [Abstract][Full Text] [Related]
34. Fibroblast growth factor receptor (FGFR) 4 correlated with the malignancy of human astrocytomas.
Yamada SM; Yamada S; Hayashi Y; Takahashi H; Teramoto A; Matsumoto K
Neurol Res; 2002 Apr; 24(3):244-8. PubMed ID: 11958417
[TBL] [Abstract][Full Text] [Related]
35. Characteristics and biological role of steroid hormone receptors in neuroepithelial tumors.
Paoletti P; Butti G; Zibera C; Scerrati M; Gibelli N; Roselli R; Magrassi L; Sica G; Rossi G; Robustelli della Cuna G
J Neurosurg; 1990 Nov; 73(5):736-42. PubMed ID: 2134312
[TBL] [Abstract][Full Text] [Related]
36. Expression of androgen receptors in astrocytoma.
Chung YG; Kim HK; Lee HK; Lee KC
J Korean Med Sci; 1996 Dec; 11(6):517-21. PubMed ID: 9008101
[TBL] [Abstract][Full Text] [Related]
37. Differential expression of inducible nitric oxide synthase mRNA in human brain tumours.
Ellie E; Loiseau H; Lafond F; Arsaut J; Demotes-Mainard J
Neuroreport; 1995 Dec; 7(1):294-6. PubMed ID: 8742473
[TBL] [Abstract][Full Text] [Related]
38. Expression of vitamin D receptor and metabolizing enzymes in multiple sclerosis-affected brain tissue.
Smolders J; Schuurman KG; van Strien ME; Melief J; Hendrickx D; Hol EM; van Eden C; Luchetti S; Huitinga I
J Neuropathol Exp Neurol; 2013 Feb; 72(2):91-105. PubMed ID: 23334593
[TBL] [Abstract][Full Text] [Related]
39. Expression and release of CD14 in astrocytic brain tumors.
Deininger MH; Meyermann R; Schluesener HJ
Acta Neuropathol; 2003 Sep; 106(3):271-7. PubMed ID: 12835948
[TBL] [Abstract][Full Text] [Related]
40. Correlation of the expression of nuclear factor-kappa B, tumor necrosis factor receptor type 1 (TNFR 1) and c-Myc with the clinical course in the treatment of malignant astrocytomas with recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2).
Yamamoto M; Fukushima T; Hayashi S; Ikeda K; Tsugu H; Kimura H; Soma G; Tomonaga M
Anticancer Res; 2000; 20(1C):611-8. PubMed ID: 10769704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
